These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19322012)

  • 1. Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell.
    He XD; Wang ZP; Wei HY; Zhou Q; Wang DG; Tian JQ; Fu SJ; Rodriguez R
    Urol Int; 2009; 82(2):209-13. PubMed ID: 19322012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro.
    Wang L; Zhang Y; Zhao J; Xiao E; Lu J; Fu S; Wang Z
    Tumour Biol; 2014 Nov; 35(11):10879-90. PubMed ID: 25085582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution and safety assessment of bladder cancer specific recombinant oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice.
    Wang F; Wang Z; Tian H; Qi M; Zhai Z; Li S; Li R; Zhang H; Wang W; Fu S; Lu J; Rodriguez R; Guo Y; Zhou L
    Curr Gene Ther; 2012 Apr; 12(2):67-76. PubMed ID: 22384806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer.
    Zhai Z; Wang Z; Fu S; Lu J; Wang F; Li R; Zhang H; Li S; Hou Z; Wang H; Rodriguez R
    Gene Ther; 2012 Nov; 19(11):1065-74. PubMed ID: 22218302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.
    Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Zhang ZW; Guo YL
    Cancer Gene Ther; 2004 Apr; 11(4):263-72. PubMed ID: 14963492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined treatment of radiation and tissue-specific recombinant oncolytic adenovirus on bladder cancer cells.
    Zhang H; Wang F; Mao C; Zhang Z; Fu S; Lu J; Zhai Z; Li R; Li S; Rodriguez R; Wang Z
    Int J Radiat Biol; 2017 Feb; 93(2):174-183. PubMed ID: 27600610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel.
    Zhang J; Ramesh N; Chen Y; Li Y; Dilley J; Working P; Yu DC
    Cancer Res; 2002 Jul; 62(13):3743-50. PubMed ID: 12097284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of mouse uroplakin II promoter on human bladder cancer cell line].
    Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Xu CX; Huang GJ; Guo YL
    Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):22-5. PubMed ID: 15059347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.
    Cao W; Tian J; Li C; Gao Y; Liu X; Lu J; Wang Y; Wang Z; Svatek RS; Rodriguez R
    Virol J; 2017 Aug; 14(1):149. PubMed ID: 28789701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo.
    Wang DG; Zhao MJ; Liu YQ; Liu XW; Niu HT; Song YF; Tian YX
    Oncotarget; 2016 Nov; 7(44):71710-71717. PubMed ID: 27687590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model.
    Melquist JJ; Kacka M; Li Y; Malaeb BS; Elmore J; Baseman AG; Hsieh JT; Koeneman KS
    Urol Oncol; 2006; 24(4):362-71. PubMed ID: 16818192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting gene expression of the mouse uroplakin II promoter to human bladder cells.
    Zhu H; Zhang ZA; Xu C; Huang G; Zeng X; Wei S; Zhang Z; Guo Y
    Urol Res; 2003 Mar; 31(1):17-21. PubMed ID: 12624658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy.
    Li S; Wang F; Zhai Z; Fu S; Lu J; Zhang H; Guo H; Hu X; Li R; Wang Z; Rodriguez R
    Oncol Lett; 2017 Aug; 14(2):2081-2088. PubMed ID: 28781650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector.
    Wang D; Wang Z; Tian J; He X; Chowdhury WH; Zhang X; Li S; Rodriguez R
    Urol Oncol; 2010; 28(2):164-9. PubMed ID: 18440837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.
    Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
    Hum Gene Ther; 2004 Jul; 15(7):637-47. PubMed ID: 15242524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratogenic Toxicity Evaluation of Bladder Cancer-Specific Oncolytic Adenovirus on Mice.
    Lu K; Wang F; Ma B; Cao W; Guo Q; Wang H; Rodriguez R; Wang Z
    Curr Gene Ther; 2021; 21(2):160-166. PubMed ID: 33334289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
    Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A
    Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
    Wang ZX; Bian HB; Yang JS; De W; Ji XH
    Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-mediated p21/Waf-1 short hairpin RNA enhances the cytotoxic effects and replicative potential of a bladder cancer-specific oncolytic adenovirus in vitro.
    Shi J; Fu S; Wang L; Tao Y; Rodriguez R; Wang Z
    Anticancer Drugs; 2017 Jan; 28(1):88-96. PubMed ID: 27622605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.
    Sachs MD; Rauen KA; Ramamurthy M; Dodson JL; De Marzo AM; Putzi MJ; Schoenberg MP; Rodriguez R
    Urology; 2002 Sep; 60(3):531-6. PubMed ID: 12350512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.